Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Annals of Intensive Care
Published in: Annals of Intensive Care 1/2021

Open Access 01-12-2021 | Bronchoscopy | Research

Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion

Authors: Margot Caron, Antoine Parrot, Alexandre Elabbadi, Sophie Dupeyrat, Matthieu Turpin, Thomas Baury, Sacha Rozencwajg, Clarisse Blayau, Jean-Pierre Fulgencio, Aude Gibelin, Pierre-Yves Blanchard, Séverine Rodriguez, Daisy Daigné, Marie-Cécile Allain, Muriel Fartoukh, Tài Pham

Published in: Annals of Intensive Care | Issue 1/2021

Login to get access

Abstract

Purpose

Flexible fiberoptic bronchoscopy is frequently used in intensive care unit, but is a source of discomfort, dyspnea and anxiety for patients. Our objective was to assess the feasibility and tolerance of a sedation using remifentanil target-controlled infusion, to perform fiberoptic bronchoscopy in awake ICU patients.

Materials, patients and methods

This monocentric, prospective observational study was conducted in awake patients requiring fiberoptic bronchoscopy. In accordance with usual practices in our center, remifentanil target-controlled infusion was used under close monitoring and adapted to the patient’s reactions. The primary objective was the rate of successful procedures without additional analgesia or anesthesia. The secondary objectives were clinical tolerance and the comfort of patients (graded from “very uncomfortable” to “very comfortable”) and operators (numeric scale from 0 to 10) during the procedure.

Results

From May 2014 to December 2015, 72 patients were included. Most of them (69%) were hypoxemic and admitted for acute respiratory failure. No additional medication was needed in 96% of the patients. No severe side-effects occurred. Seventy-eight percent of patients described the procedure as “comfortable or very comfortable”. Physicians rated their comfort with a median [IQR] score of 9 [8–10].

Conclusion

Remifentanil target-controlled infusion administered to perform awake fiberoptic bronchoscopy in critically ill patients is feasible without requirement of additional analgesics or sedative drugs. Clinical tolerance as well as patients’ and operators’ comfort were good to excellent. This technique could benefit patients’ experience.
Appendix
Available only for authorised users
Literature
1.
Puntillo KA, Morris AB, Thompson CL, Stanik-Hutt J, White CA, Wild LR. Pain behaviors observed during six common procedures: results from Thunder Project II*: Critical Care Medicine. 2004;32:421–7.PubMedCrossRef
2.
Puntillo KA, Max A, Timsit J-F, Vignoud L, Chanques G, Robleda G, et al. Determinants of procedural pain intensity in the intensive care unit: the Europain study. Am J Respir Crit Care Med. 2014;89(1):39-47.CrossRef
3.
Barlési F, Dissard-Barriol E, Gimenez C, Doddoli C, Greillier L. Kleisbauer J-P. Tolerance of fiberoptic bronchoscopy by self-administered questionnaire: in the words of the patients. Rev Mal Respir. 2003;20:335–40.PubMed
4.
Diette GB, White P, Terry P, Jenckes M, Wise RA, Rubin HR. Quality assessment through patient self-report of symptoms prefiberoptic and postfiberoptic bronchoscopy. Chest. 1998;114:1446–53.PubMedCrossRef
5.
Merskey H. Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979;6:249.
6.
7.
8.
Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93:853–8.PubMedCrossRef
9.
Davidson JE, Harvey MA, Bemis-Dougherty A, Smith JM, Hopkins RO. Implementation of the pain, agitation, and delirium clinical practice guidelines and promoting patient mobility to prevent post-intensive care syndrome. Crit Care Med. 2013;41:S136–45.PubMedCrossRef
10.
Myhren H, Ekeberg O, Toien K, Karlsson S, Stokland O. Posttraumatic stress, anxiety and depression symptoms in patients during the first year post intensive care unit discharge. Crit Care. 2010;14:R14.PubMedPubMedCentralCrossRef
11.
Novaes MA, Knobel E, Bork AM, Pavão OF, Nogueira-Martins LA, Ferraz MB. Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med. 1999;25:1421–6.PubMedCrossRef
12.
Payen J-F, Bosson J-L, Chanques G, Mantz J, Labarere J. Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit. Anesthesiology. 2009;111:1308–16.PubMedCrossRef
13.
Gélinas C, Johnston C. Pain assessment in the critically ill ventilated adult: validation of the Critical-Care Pain Observation Tool and physiologic indicators. Clin J Pain. 2007;23:497–505.PubMedCrossRef
14.
Payen JF, Bru O, Bosson JL, Lagrasta A, Novel E, Deschaux I, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001;29:2258–63.PubMedCrossRef
15.
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:278–80.CrossRef
16.
Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993;79:881–92.PubMedCrossRef
17.
Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II Model application Anesthesiology. 1997;86:24–33.PubMed
18.
Hoke JF, Shlugman D, Dershwitz M, Michałowski P, Malthouse-Dufore S, Connors PM, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology. 1997;87:533–41.PubMedCrossRef
19.
Dershwitz M, Hoke JF, Rosow CE, Michałowski P, Connors PM, Muir KT, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology. 1996;84:812–20.PubMedCrossRef
20.
Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med. 2013;39:53–8.PubMedCrossRef
21.
Rezaiguia-Delclaux S, Laverdure F, Kortchinsky T, Lemasle L, Imbert A, Stéphan F. Fiber optic bronchoscopy and remifentanil target-controlled infusion in critically ill patients with acute hypoxaemic respiratory failure: A descriptive study. Anaesth Crit Care Pain Med. 2017;36:273–7.PubMedCrossRef
22.
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338–44.PubMedCrossRef
23.
Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–51.PubMed
24.
Puchner W, Egger P, Pühringer F, Löckinger A, Obwegeser J, Gombotz H. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand. 2002;46:350–4.PubMedCrossRef
25.
Gonzalez R, De-La-Rosa-Ramirez I, Maldonado-Hernandez A, Dominguez-Cherit G. Should patients undergoing a bronchoscopy be sedated? Acta Anaesthesiol Scand. 2003;47:411–5.PubMedCrossRef
26.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.CrossRef
27.
Albertini RE, Harrell JH, Kurihara N, Moser KM. Arterial hypoxemia induced by fiberoptic bronchoscopy. JAMA. 1974;230:1666–7.PubMedCrossRef
28.
Cracco C, Fartoukh M, Prodanovic H, Azoulay E, Chenivesse C, Lorut C, et al. Safety of performing fiberoptic bronchoscopy in critically ill hypoxemic patients with acute respiratory failure. Intensive Care Med. 2013;39:45–52.PubMedCrossRef
29.
30.
Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18:5994–6004.PubMedCrossRef
31.
Del Blanco Narciso BB, Jimeno Fernandez C, Almendral Garrote J, Anadon Baselga MJ, Zaballos Garcia M. Effects of remifentanil on the cardiac conduction system. Our experience in the study of remifentanil electrophysiological properties. Curr Pharm Des. 2014;20:5489–96.
32.
Zaballos M, Jimeno C, Almendral J, Atienza F, Patiño D, Valdes E, et al. Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model. Br J Anaesth. 2009;103:191–8.PubMedCrossRef
33.
DeSouza G, Lewis MC, TerRiet MF. Severe bradycardia after remifentanil. Anesthesiology 1997;87:1019–20.PubMedCrossRef
34.
Poi PJ, Chuah SY, Srinivas P, Liam CK. Common fears of patients undergoing bronchoscopy. Eur Respir J. 1998;11:1147–9.PubMedCrossRef
35.
Lallo A, Billard V, Bourgain J-L. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg. 2009;108:852–7.PubMedCrossRef
36.
Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. BJA: British Journal of Anaesthesia. 2008;100:125–30.
37.
Soffler MI, Rose A, Hayes MM, Banzett R, Schwartzstein RM. Treatment of acute dyspnea with morphine to avert respiratory failure. Ann Am Thorac Soc. 2017;14:584–8.PubMedPubMedCentralCrossRef
38.
Banzett RB, Adams L, O’Donnell CR, Gilman SA, Lansing RW, Schwartzstein RM. Using laboratory models to test treatment. Am J Respir Crit Care Med. 2011;184:920–7.PubMedPubMedCentralCrossRef
39.
40.
Putinati S, Ballerin L, Corbetta L, Trevisani L, Potena A. Patient satisfaction with conscious sedation for bronchoscopy. Chest. 1999;115:1437–40.PubMedCrossRef
41.
Greig JH, Cooper SM, Kasimbazi HJN, Monie RDH, Fennerty AG, Watson B. sedation for fibre optic bronchoscopy. Resp Med. 1995;89:53–6.CrossRef
42.
Yıldırım F, Özkaya Ş, Yurdakul AS. Factors affecting patients’ comfort during fiberoptic bronchoscopy and endobronchial ultrasound. J Pain Res. 2017;10:775–81.PubMedPubMedCentralCrossRef
43.
Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2012;108:503–11.PubMedCrossRef
44.
Clouzeau B, Bui H-N, Guilhon E, Grenouillet-Delacre M, Leger MS, Saghi T, et al. Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients. Intensive Care Med. 2011;37:1969–75.PubMedCrossRef
45.
Bellolio MF, Gilani WI, Barrionuevo P, Murad MH, Erwin PJ, Anderson JR, et al. Incidence of adverse events in adults undergoing procedural sedation in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2016;23:119–34.PubMedPubMedCentralCrossRef
46.
Schmidt M, Banzett RB, Raux M, Morélot-Panzini C, Dangers L, Similowski T, et al. Unrecognized suffering in the ICU: addressing dyspnea in mechanically ventilated patients. Intensive Care Med. 2014;40:1–10.PubMedCrossRef
47.
von Leupoldt A, Dahme B. Experimental comparison of dyspnea and pain. Behav Res Methods. 2007;39:137–43.CrossRef
48.
Beaussier M, Genty T, Lescot T, Aissou M. Influence of pain on postoperative ventilatory disturbances. Management and expected benefits. Ann Fr Anesth Reanim. 2014;33:484–6.
49.
Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68(Suppl 1):i1-44.PubMedCrossRef
50.
Ni Y-L, Lo Y-L, Lin T-Y, Fang Y-F, Kuo H-P. Conscious sedation reduces patient discomfort and improves satisfaction in flexible bronchoscopy. Chang Gung Med J. 2010;33:443–52.PubMed
Metadata
Title
Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion
Authors
Margot Caron
Antoine Parrot
Alexandre Elabbadi
Sophie Dupeyrat
Matthieu Turpin
Thomas Baury
Sacha Rozencwajg
Clarisse Blayau
Jean-Pierre Fulgencio
Aude Gibelin
Pierre-Yves Blanchard
Séverine Rodriguez
Daisy Daigné
Marie-Cécile Allain
Muriel Fartoukh
Tài Pham
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2021
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-021-00832-6

Other articles of this Issue 1/2021

Annals of Intensive Care 1/2021 Go to the issue

Research

Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study

Research

Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock

Research

Mental health and stress among ICU healthcare professionals in France according to intensity of the COVID-19 epidemic

Review

Admission criteria and management of critical care patients in a pandemic context: position of the Ethics Commission of the French Intensive Care Society, update of April 2021

Research

High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study

Research

Admission serum myoglobin and the development of acute kidney injury after major trauma